A nonsteroidal aromatase inhibitor used in the treatment and prevention of breast cancer. It has been observed to have fewer adverse side effects than tamoxifen.
- ‘Perhaps we could get rid of 70% of breast cancer by using anastrozole as a preventive therapy.’
- ‘Consultant oncologist Dr David Fennelly, who is a member of the Irish Cancer Society's Medical Committee, said anastrozole was a valuable addition to existing drugs for the treatment of breast cancer.’
- ‘Much of the success for the development of tamoxifen, goserilin, and anastrozole in the treatment of early or metastatic breast cancer can be attributed to Ian's ceaseless energy and zeal.’
- ‘The Food and Drug Administration approved anastrozole for cancer treatment in 1996, and another drug letrozole in 1997.’
- ‘The ATAC study is an international collaboration which compared the safety and efficacy of tamoxifen with anastrozole alone and the combination of both drugs for 5 years.’